Ken Takanashi, Director, 10% Owner at Satsuma Pharmaceuticals, Inc. (STSA), bought 44,107,162 shares at $0.91 ($40.1M) on 2023-06-06, disclosed to the SEC on 2023-06-08.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.91 | 22,053,581 | $20.1M | 50.0% |
| 2 | $0.91 | 22,053,581 | $20.1M | 50.0% |
| Total | $0.91 avg | 44,107,162 | $40.1M | 100% |
| Filing → |
| STSA | BUY | 2019-09-17 | $3.5M | — | Filing → |
| WVE | BUY | 2015-11-18 | $2.0M | — | Filing → |